Ngam Advisors L.P. cut its stake in shares of Stericycle Inc. (NASDAQ:SRCL) by 1.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 102,287 shares of the company’s stock after selling 1,755 shares during the period. Ngam Advisors L.P. owned about 0.12% of Stericycle worth $8,197,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in SRCL. Schaper Benz & Wise Investment Counsel Inc. WI boosted its position in shares of Stericycle by 10.0% in the second quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 98,058 shares of the company’s stock valued at $10,210,000 after buying an additional 8,905 shares in the last quarter. Oakbrook Investments LLC bought a new position in shares of Stericycle during the second quarter valued at $13,871,000. Minneapolis Portfolio Management Group LLC bought a new position in shares of Stericycle during the second quarter valued at $21,267,000. Douglas Lane & Associates LLC boosted its position in shares of Stericycle by 6.6% in the second quarter. Douglas Lane & Associates LLC now owns 346,276 shares of the company’s stock valued at $36,054,000 after buying an additional 21,370 shares in the last quarter. Finally, Mcdonald Capital Investors Inc. CA boosted its position in shares of Stericycle by 78.1% in the second quarter. Mcdonald Capital Investors Inc. CA now owns 390,060 shares of the company’s stock valued at $40,613,000 after buying an additional 171,010 shares in the last quarter. Hedge funds and other institutional investors own 92.46% of the company’s stock.

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Stericycle Inc. (NASDAQ:SRCL) traded down 3.153% during mid-day trading on Wednesday, hitting $73.439. The stock had a trading volume of 586,898 shares. The company has a market cap of $6.25 billion, a price-to-earnings ratio of 26.695 and a beta of 0.17. The company has a 50 day moving average price of $75.43 and a 200-day moving average price of $88.39. Stericycle Inc. has a one year low of $72.20 and a one year high of $128.94.

Stericycle (NASDAQ:SRCL) last announced its earnings results on Thursday, October 27th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.17 by $0.07. Stericycle had a net margin of 7.52% and a return on equity of 15.33%. The firm had revenue of $890.10 million for the quarter, compared to analyst estimates of $899.87 million. During the same quarter last year, the business earned $1.08 earnings per share. Stericycle’s revenue was up 23.9% compared to the same quarter last year. Equities analysts expect that Stericycle Inc. will post $4.74 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This news story was first published by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this news story on another website, it was illegally stolen and reposted in violation of United States & international copyright law. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2016/11/30/stericycle-inc-srcl-position-decreased-by-ngam-advisors-l-p.html.

Several research analysts have recently weighed in on the company. Wedbush restated a “neutral” rating and set a $82.00 target price (down from $85.00) on shares of Stericycle in a report on Tuesday, November 15th. Goldman Sachs Group Inc. cut Stericycle from a “neutral” rating to a “sell” rating and set a $60.00 target price on the stock. in a report on Thursday, November 3rd. Zacks Investment Research upgraded Stericycle from a “strong sell” rating to a “hold” rating in a report on Monday, October 31st. Stifel Nicolaus upgraded Stericycle from a “hold” rating to a “buy” rating and set a $90.00 target price on the stock in a report on Friday, October 28th. Finally, Jefferies Group set a $108.00 target price on Stericycle and gave the stock a “buy” rating in a report on Tuesday, October 25th. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $92.75.

In related news, EVP John P. Schetz sold 1,398 shares of the firm’s stock in a transaction that occurred on Wednesday, September 14th. The shares were sold at an average price of $81.85, for a total transaction of $114,426.30. Following the sale, the executive vice president now owns 1,088 shares in the company, valued at $89,052.80. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 3.30% of the company’s stock.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.